Short Interest in Jin Medical International Ltd. (NASDAQ:ZJYL) Rises By 72.1%

Jin Medical International Ltd. (NASDAQ:ZJYLGet Free Report) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 18,894 shares, an increase of 72.1% from the May 31st total of 10,979 shares. Based on an average daily volume of 1,462,657 shares, the short-interest ratio is presently 0.0 days. Currently, 0.2% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut Jin Medical International from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Jin Medical International has an average rating of “Sell”.

Get Our Latest Research Report on Jin Medical International

Jin Medical International Price Performance

Jin Medical International stock remained flat at $1.89 during midday trading on Thursday. 4,928 shares of the company were exchanged, compared to its average volume of 162,265. The company’s 50 day simple moving average is $2.35 and its 200 day simple moving average is $2.79. Jin Medical International has a 12 month low of $1.64 and a 12 month high of $17.18.

About Jin Medical International

(Get Free Report)

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Read More

Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.